| PharmaSUG |
2020 |
Assessing Performance of Risk-based Testing |
Bill Coar |
source |
11 |
| PHUSE US |
2019 |
Effective Presentations of CTCAE-graded Laboratory Data |
William Coar |
source presentation source |
7 |
| WUSS |
2018 |
CDISC in Phase I/II Studies: Approaches to adopting standards for CSR deliverables |
Emily Woolley |
source |
9 |
| PharmaSUG |
2018 |
Risk-based Validation in Clinical Trial Reporting: Focus on What Matters Most |
William Coar |
source |
10 |
| PharmaSUG |
2017 |
Data Monitoring Committee Report Programming: Considering a Risk-Based Approach to Quality Control |
Bill Coar |
source |
9 |
| SGF |
2017 |
Quality Control Programming: A Lost Art? |
Bill Coar |
source |
15 |
| PharmaSUG |
2016 |
Strategic Considerations for CDISC Implementation |
William Coar |
source |
6 |
| PharmaSUG |
2015 |
Enhancing Infrastructure for Growth |
William Coar |
source |
5 |
| SGF |
2015 |
Enhancing Infrastructure for Growth [presentation] |
|
source |
8 |
| WUSS |
2014 |
Enhancing Infrastructure for Growth [presentation] |
Bill Coar |
|
7 |